CVS Health issues $3B junior subordinated notes: 7.0% due 2055, 6.75% due 2054

CVS HEALTH Corp

Issued $2.25B of 7.000% Series A Junior Subordinated Notes due 2055 and $750M of 6.750% Series B Junior Subordinated Notes due 2054.
Expected net proceeds ~$2.963B after underwriting discounts and expenses.
Closing expected December 10, 2024; lead underwriters include Barclays, Citigroup, Goldman Sachs.
Registration statement on Form S-3ASR (File No. 333-272200) effective May 25, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.